Key result
Aortic valve replacement using the Smeloff-Cutter prosthesis yielded an actuarial survival rate of 69% at 5 years and 61.1% at 8 years, with 88% of surviving patients reporting improvement.
Why the study?
Does single aortic valve replacement using the Smeloff-Cutter prosthesis improve long-term survival in patients with symptomatic aortic valve disease?
Cohort (n=187)
Does single aortic valve replacement using the Smeloff-Cutter prosthesis improve long-term survival in patients with symptomatic aortic valve disease?
Aortic valve replacement with the Smeloff-Cutter prosthesis yields a 61.1% survival rate at 8 years, significantly improving life expectancy and symptoms compared to medical management of symptomatic aortic stenosis.
Answers are grounded in this paper and cite their sources.
Associated with favorable survival after AVR; leaves open applicability to modern valves and randomized comparisons.
The long-term prognosis of 187 consecutive patients who received single aortic valve replacement using Smeloff-Cutter prosthesis was studied. Of the 163 patients who survived the operation, a long-term follow-up (up to eight years) was obtained in 153 patients (95%). A total of 34 patients (22%) died during the follow-up period. Including the hospital mortality, the actuarial survival rate of our patients with Smeloff-Cutter prosthesis was 0.69 after the fifth year and 0.611 after the eighth year of follow-up. This is similar to the actuarial survival rate of patients with Starr-Edwards prosthesis but it appears significantly better than the expected survival rate of symptomatic patients with aortic stenosis treated without surgery. Thus, this result supports the contention that aortic valve surgery in properly selected patients can prolong life expectancy in addition to relieving symptoms in patients with aortic valve disease. The majority of surviving patients reported to have improved (88%) since the operation and to be symptom free (82%).
No takes yet. Share an insight, caveat, or question.
Lee et al. (1975) conducted a cohort in Aortic valve disease (n=187). Aortic valve replacement using Smeloff-Cutter prosthesis vs. Starr-Edwards prosthesis and expected survival without surgery was evaluated on Actuarial survival rate after the eighth year of follow-up. Aortic valve replacement using the Smeloff-Cutter prosthesis yielded an actuarial survival rate of 69% at 5 years and 61.1% at 8 years, with 88% of surviving patients reporting improvement.
Synapse has enriched 10 related papers. Consider them for comparative context: